BioCentury | Jan 8, 2021
Management Tracks

Moderna hires chief commercial officer as it ramps up COVID vaccine rollout; plus MorphoSys, Silence, Verastem, Viking, Destiny and Allen Institute

...focus on prevention, hired Stephanie Bewick as it first CBO. She was VP of business development at Summit Therapeutics Inc....
BioCentury | Jun 20, 2020
Management Tracks

Nurix bolsters leadership; plus Lynch named Xilio chairman, Edgewise, BioXCel, Catabasis, Catalyst and more

...hired Meri Williams as CTO, a new position. She was CTO of Monzo Bank Ltd. Summit Therapeutics...
...Staff Nurix Therapeutics Inc. Xilio Therapeutics Inc. Edgewise Therapeutics BioXcel Therapeutics Inc. Catabasis Pharmaceuticals Inc. Catalyst BioMedica Kronos Bio Inc. Canbridge Pharmaceuticals Inc. Healx Ltd. Summit Therapeutics...
BioCentury | Jun 13, 2020
Management Tracks

Sawyers to head AACR next year; plus Quell, CalciMedica, Bigfoot, Celyad, Praxis, Affimed and more

...BioCentury Staff Quell Therapeutics Ltd. American Association for Cancer Research CalciMedica Inc. Celyad S.A. Confo Therapeutics N.V. Praxis Precision Medicines Inc. Affimed N.V. Summit Therapeutics...
BioCentury | Apr 18, 2020
Management Tracks

PTC names Matthew Klein as chief development officer; plus Cardurion, Sangamo, TCR2, Five Prime and more

...Inc. hired Edgardo Baracchini as CBO. He was CBO of Xencor Inc. (NASDAQ:XNCR). Antibiotics company Summit Therapeutics...
BioCentury | Feb 29, 2020
Management Tracks

Brandicourt joins Alnylam's board: plus Bayer, Jazz, Halozyme, Arena, Aurinia, Adverum, Neoleukin, Centogene, Epirium, Insilico, Nouscom, Eloxx, Nordic, Summit,

...down to pursue other opportunities. CTO Lars Nieba will serve as interim CEO. Antibiotics company Summit Therapeutics...
BioCentury | Jan 25, 2020
Company News

Management tracks: Galapagos promotes Manto to CCO; plus Guardant, Horizon, Acceleron, Lilly, Krystal, Kura and more

...CSO. David Roblin has resigned as COO, CMO and president of R&D at antibiotics play Summit Therapeutics...
BioCentury | Oct 4, 2019
Clinical News

Summit’s C. diff benefits for ridinilazole continue with early, sustained effect on quality of life

...as they develop new value assessment frameworks to capture the benefits of antibiotics. On Thursday, Summit Therapeutics...
...to ClinicalTrials.gov, the estimated primary completion date is September 2021. Inhua Muijrers-Chen, Associate Editor Ridinilazole (smt19969, SMT 19969) Summit Therapeutics...
BioCentury | Sep 12, 2019
Preclinical News

Sept. 12 Preclinical Quick Takes: Stephen Quake newco reveals epigenomic platform; plus Personal Genome, Summit and Biolife4D

...Step Forward for Tissue-Agnostic Diagnostics” ). Summit presents data on DDS-04 to treat Enterobacteria infections Summit Therapeutics...
...goal is to produce functional, replica hearts for human transplant. BioCentury Staff Personal Genome Diagnostics Inc. Guardant Health Inc. Summit Therapeutics...
BioCentury | Jul 11, 2019
Politics & Policy

Former Crick COO outlines to do list for U.K. antibiotics initiative to succeed

...of use of new antibiotics, said Roblin, who is COO and CMO of antibiotics company Summit Therapeutics...
...investment into emerging science and technology." Inhua Muijrers-Chen, Associate Editor National Institute for Health and Care Excellence (NICE) Summit Therapeutics...
BioCentury | Jul 9, 2019
Politics & Policy

U.K. launches subscription model to pay for antibiotics

...hampered investment in antibiotics research so long." David Roblin, COO and CMO of antibiotics company Summit Therapeutics...
...told BioCentury. Inhua Muijrers-Chen, Associate Editor Ridinilazole (smt19969, SMT 19969) National Institute for Health and Care Excellence (NICE) NHS England Summit Therapeutics...
Items per page:
1 - 10 of 157
BioCentury | Jan 8, 2021
Management Tracks

Moderna hires chief commercial officer as it ramps up COVID vaccine rollout; plus MorphoSys, Silence, Verastem, Viking, Destiny and Allen Institute

...focus on prevention, hired Stephanie Bewick as it first CBO. She was VP of business development at Summit Therapeutics Inc....
BioCentury | Jun 20, 2020
Management Tracks

Nurix bolsters leadership; plus Lynch named Xilio chairman, Edgewise, BioXCel, Catabasis, Catalyst and more

...hired Meri Williams as CTO, a new position. She was CTO of Monzo Bank Ltd. Summit Therapeutics...
...Staff Nurix Therapeutics Inc. Xilio Therapeutics Inc. Edgewise Therapeutics BioXcel Therapeutics Inc. Catabasis Pharmaceuticals Inc. Catalyst BioMedica Kronos Bio Inc. Canbridge Pharmaceuticals Inc. Healx Ltd. Summit Therapeutics...
BioCentury | Jun 13, 2020
Management Tracks

Sawyers to head AACR next year; plus Quell, CalciMedica, Bigfoot, Celyad, Praxis, Affimed and more

...BioCentury Staff Quell Therapeutics Ltd. American Association for Cancer Research CalciMedica Inc. Celyad S.A. Confo Therapeutics N.V. Praxis Precision Medicines Inc. Affimed N.V. Summit Therapeutics...
BioCentury | Apr 18, 2020
Management Tracks

PTC names Matthew Klein as chief development officer; plus Cardurion, Sangamo, TCR2, Five Prime and more

...Inc. hired Edgardo Baracchini as CBO. He was CBO of Xencor Inc. (NASDAQ:XNCR). Antibiotics company Summit Therapeutics...
BioCentury | Feb 29, 2020
Management Tracks

Brandicourt joins Alnylam's board: plus Bayer, Jazz, Halozyme, Arena, Aurinia, Adverum, Neoleukin, Centogene, Epirium, Insilico, Nouscom, Eloxx, Nordic, Summit,

...down to pursue other opportunities. CTO Lars Nieba will serve as interim CEO. Antibiotics company Summit Therapeutics...
BioCentury | Jan 25, 2020
Company News

Management tracks: Galapagos promotes Manto to CCO; plus Guardant, Horizon, Acceleron, Lilly, Krystal, Kura and more

...CSO. David Roblin has resigned as COO, CMO and president of R&D at antibiotics play Summit Therapeutics...
BioCentury | Oct 4, 2019
Clinical News

Summit’s C. diff benefits for ridinilazole continue with early, sustained effect on quality of life

...as they develop new value assessment frameworks to capture the benefits of antibiotics. On Thursday, Summit Therapeutics...
...to ClinicalTrials.gov, the estimated primary completion date is September 2021. Inhua Muijrers-Chen, Associate Editor Ridinilazole (smt19969, SMT 19969) Summit Therapeutics...
BioCentury | Sep 12, 2019
Preclinical News

Sept. 12 Preclinical Quick Takes: Stephen Quake newco reveals epigenomic platform; plus Personal Genome, Summit and Biolife4D

...Step Forward for Tissue-Agnostic Diagnostics” ). Summit presents data on DDS-04 to treat Enterobacteria infections Summit Therapeutics...
...goal is to produce functional, replica hearts for human transplant. BioCentury Staff Personal Genome Diagnostics Inc. Guardant Health Inc. Summit Therapeutics...
BioCentury | Jul 11, 2019
Politics & Policy

Former Crick COO outlines to do list for U.K. antibiotics initiative to succeed

...of use of new antibiotics, said Roblin, who is COO and CMO of antibiotics company Summit Therapeutics...
...investment into emerging science and technology." Inhua Muijrers-Chen, Associate Editor National Institute for Health and Care Excellence (NICE) Summit Therapeutics...
BioCentury | Jul 9, 2019
Politics & Policy

U.K. launches subscription model to pay for antibiotics

...hampered investment in antibiotics research so long." David Roblin, COO and CMO of antibiotics company Summit Therapeutics...
...told BioCentury. Inhua Muijrers-Chen, Associate Editor Ridinilazole (smt19969, SMT 19969) National Institute for Health and Care Excellence (NICE) NHS England Summit Therapeutics...
Items per page:
1 - 10 of 157